Jiaxi He

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

Wenhua Liang, Jiaxi He, Yaxing Shen et al. · Journal of Clinical Oncology · 2017 · 358 citations · Full text

Medicine, Biostatistics, Oncology +17

Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study

Chenyang Dai, Jianfei Shen, Yijiu Ren et al. · Journal of Clinical Oncology · 2016 · 245 citations

Medicine, Oncology, Surgery +15

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma

Jun Huang, Xing‐Xing Fan, Jiaxi He et al. · Oncotarget · 2016 · 85 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals

Kelin She, Shenghua Fang, Wei Du et al. · Cancer Cell International · 2019 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Nomogram prediction for the survival of the patients with small cell lung cancer

Hui Pan, Xiaoshun Shi, Dakai Xiao et al. · Journal of Thoracic Disease · 2017 · 69 citations · Full text

Medicine, Oncology, Molecular Oncology +16